CSIMarket
 

Rockwell Medical inc   (NASDAQ: RMTI)

Rockwell Medical Inc 's

Competitiveness




 

RMTI Sales vs. its Competitors Q2 2026



Comparing the current results to its competitors, Rockwell Medical Inc reported Revenue increase in the 2 quarter 2026 by 14.69 % year on year.
The sales growth was above Rockwell Medical Inc 's competitors' average revenue growth of 3.09 %, achieved in the same quarter.

List of RMTI Competitors





Revenue Growth Comparisons




Net Income Comparison


Rockwell Medical inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  RMTI Stock Performance Comparisons



  

Overall company Market Share Q2 2026

Rockwell Medical inc achieved revenue growth of 14.69 % in Overall company, and improved market share, to approximately 0.15 %.


<<  More on RMTI Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Rockwell Medical inc




Elite Pharmaceuticals Inc
Share Performance



-29.14%
30 Days



Elite Pharmaceuticals Inc
Profile

Elite Pharmaceuticals Inc. is a pharmaceutical company that specializes in developing and manufacturing generic and abuse-deterrent controlled-release products. Their business model focuses on conducting research, obtaining regulatory approvals, and licensing their products to other pharmaceutical companies for commercialization and distribution.

More about Elite Pharmaceuticals Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 287.922 mill. $ 140.130 mill. $ 56.668 mill.


Therapeuticsmd Inc
Share Performance



+30.91%
This Year



Therapeuticsmd Inc
Profile

TherapeuticsMD Inc is a pharmaceutical company that focuses on developing and commercializing innovative hormone therapy products for women. Their business model revolves around research, development, and marketing of prescription and over-the-counter products catering to women's health needs. By leveraging strategic partnerships and collaborations, they aim to bring their products to market, ultimately improving the quality of life for women.

More about Therapeuticsmd Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 25.149 mill. $ 3.270 mill. $ -0.217 mill.


Teva Pharmaceutical Industries Limited
Share Performance



+16.58%
This Year



Teva Pharmaceutical Industries Limited
Profile

Teva Pharmaceutical Industries Limited is a multinational pharmaceutical company that focuses on the development, production, and marketing of generic and specialty medicines. They aim to provide affordable and accessible healthcare solutions to patients worldwide.

More about Teva Pharmaceutical Industries Limited's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 42,033.200 mill. $ 14,105.000 mill. $ 709.000 mill.


Puma Biotechnology Inc
Share Performance



-4.89%
Over The Past 5 Days



Puma Biotechnology Inc
Profile

Puma Biotechnology Inc operates as a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for the treatment of cancer. Their business model revolves around identifying promising preclinical and clinical drug candidates, conducting rigorous research and development, and seeking regulatory approval for their products. Puma Biotechnology Inc strives to effectively market and distribute their approved therapeutics to provide patients with potentially life-saving treatment options.

More about Puma Biotechnology Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 470.739 mill. $ 231.244 mill. $ 26.718 mill.


Nephros Inc
Share Performance



+5.39%
30 Days



Nephros Inc
Profile

Nephros Inc operates under a business model focused on developing and marketing specialty medical products and technologies for renal disease patients. The company aims to provide innovative filtration and purification solutions to improve the quality of life for individuals with renal disorders.

More about Nephros Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 51.063 mill. $ 21.686 mill. $ 1.736 mill.

11 more competitors available

Sign in to see all competitors

Sources: Rockwell Medical inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Rockwell Medical inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.